Pages

Friday, 7 June 2019

Why Investors Should Keep an Eye on the Oklahoma Opioid Trial Against Johnson & Johnson


Why Investors Should Keep an Eye on the Oklahoma Opioid Trial Against Johnson & Johnson



The case, which is premised on a unproven legal theory, could impact the course of future opioid litigation.

No comments:

Post a Comment